Gemma Sánchez-Espín
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gemma Sánchez-Espín has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Porras
Unidad de Gestión Clínica del Corazón y Patología Cardiovascular, Servicio de Cirugía Cardíaca, Hospital Universitario Virgen de la Victoria, Málaga, España
24 shared publications Miguel Such
Unidad de Gestión Clínica del Corazón, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga (UMA), CIBERCV Enfermedades Cardiovasculares, Málaga, Spain
15 shared publications- Emiliano Andrés Rodríguez Caulo
Cardiovascular Surgery Department, Virgen de la Macarena University Hospital, Sevilla, Spain
13 shared publications José M. Melero
11 shared publications- Manuel Francisco Jiménez Navarro
IBIMA Plataforma Bionand (Instituto de Investigación Biomédica de Málaga), Spain
8 shared publications Arantza Guzón
6 shared publications
Latest Publications
- 8 October 2020
- Published by IMR Press in The Heart Surgery Forum
- Vol. 23 (6) , E763-E769
Outcomes of Isolated Tricuspid Valve Surgery
Background: Isolated tricuspid valve surgery is a rarely performed procedure and traditionally is associated with a bad prognosis, although its clinical outcomes still are little known. The aim of this study was to assess the short- and long-term clinical outcomes obtained at our center after isolated tricuspid valve surgery as treatment for severe tricuspid regurgitation. Methods: This retrospective study included 71 consecutive patients with severe tricuspid regurgitation who underwent isolated tricuspid valve surgery between December 1996 and December 2017. Perioperative and long-term mortality, tricuspid valve reoperation, and functional class were analyzed after follow up. Results: Regarding surgery, 7% of patients received a De Vega annuloplasty, 14.1% an annuloplasty ring, 11.3% a mechanical prosthesis, and 67.6% a biological prosthesis. Perioperative mortality was 12.7% and no variable was shown to be predictive of this event. After a median follow up of 45.5 months, long-term mortality was 36.6%, and the multivariate analysis identified atrial fibrillation as the only predictor (Hazard Ratio 3.014, 95% confidence interval 1.06-8.566; P = 0.038). At the end of follow up, 63.6% of survivors had functional class I. Conclusions: Isolated tricuspid valve surgery was infrequent in our center. Perioperative mortality was high, as was long-term mortality. However, a high percentage of survivors were barely symptomatic after follow up.
- 8 October 2020
- Published by IMR Press in The Heart Surgery Forum
- Vol. 23 (6) , E763-E769
Outcomes of Isolated Tricuspid Valve Surgery
Background: Isolated tricuspid valve surgery is a rarely performed procedure and traditionally is associated with a bad prognosis, although its clinical outcomes still are little known. The aim of this study was to assess the short- and long-term clinical outcomes obtained at our center after isolated tricuspid valve surgery as treatment for severe tricuspid regurgitation. Methods: This retrospective study included 71 consecutive patients with severe tricuspid regurgitation who underwent isolated tricuspid valve surgery between December 1996 and December 2017. Perioperative and long-term mortality, tricuspid valve reoperation, and functional class were analyzed after follow up. Results: Regarding surgery, 7% of patients received a De Vega annuloplasty, 14.1% an annuloplasty ring, 11.3% a mechanical prosthesis, and 67.6% a biological prosthesis. Perioperative mortality was 12.7% and no variable was shown to be predictive of this event. After a median follow up of 45.5 months, long-term mortality was 36.6%, and the multivariate analysis identified atrial fibrillation as the only predictor (Hazard Ratio 3.014, 95% confidence interval 1.06-8.566; P = 0.038). At the end of follow up, 63.6% of survivors had functional class I. Conclusions: Isolated tricuspid valve surgery was infrequent in our center. Perioperative mortality was high, as was long-term mortality. However, a high percentage of survivors were barely symptomatic after follow up.
- 1 February 2019
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 72 (2) , 178-180
Resultados del tratamiento quirúrgico de la insuficiencia tricuspídea grave en una serie contemporánea
- 1 February 2019
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 72 (2) , 178-180
Resultados del tratamiento quirúrgico de la insuficiencia tricuspídea grave en una serie contemporánea
- Open Access
- 17 February 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 1-8
Quality of life, satisfaction and outcomes after ministernotomy versus full sternotomy isolated aortic valve replacement (QUALITY-AVR): study protocol for a randomised controlled trial
During the last decade, the use of ministernotomy in cardiac surgery has increased. Quality of life and patient satisfaction after ministernotomy have never been compared to conventional full sternotomy in randomised trials. The aim of the study is to determine if this minimally invasive approach improves quality of life, satisfaction and clinical morbimortality outcomes. The QUALITY-AVR trial is a single-blind, single-centre, independent, and pragmatic randomised clinical trial comparing ministernotomy (“J” shaped upper hemisternotomy toward right 4th intercostal space) to full sternotomy in patients with isolated severe aortic stenosis scheduled for elective aortic valve replacement. One hundred patients will be randomised in a 1:1 computational fashion. Sample size was determined for the primary end point with alpha error of 0.05 and with power of 90% in detecting differences between intervention groups of ≥ 0.10 points in change from baseline quality of life Questionnaire EuroQOL-index (EQ-5D-5 L®), measured at 1, 6 or 12 months. Secondary endpoints are: the differences in change from other baseline EQ-5D-5 L® utilities (visual analogue scale, Health Index and Severity Index), cardiac surgery specific satisfaction questionnaire (SATISCORE®), a combined safety endpoint of four major adverse complications at 1 month (all-cause mortality, acute myocardial infarction, neurologic events and acute renal failure), bleeding through drains within the first 24 h, intubation time, postoperative hospital and intensive care unit length of stay, transfusion needs during the first 72 h and 1-year survival rates. Clinical follow up is scheduled at baseline, 1, 6, and 12 months after randomization. All clinical outcomes are recorded following the Valve Academic Research Consortium 2 criteria. The QUALITY-AVR trial aims to test the hypothesis that ministernotomy improves quality of life, satisfaction and clinical outcomes in patients referred for isolated aortic valve replacement. Statistically significant differences favouring ministernotomy could modify the surgical “gold standard” for aortic stenosis surgery, and subsequently the need to change the control group in transcatheter aortic valve implantation trials. Recruitment started on 18 March 2016. In November 2017, 75 patients were enrolled. ClinicalTrials.gov, NCT02726087. Registered on 13 March 2016.
- 17 February 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 1-8
Open AccessQuality of life, satisfaction and outcomes after ministernotomy versus full sternotomy isolated aortic valve replacement (QUALITY-AVR): study protocol for a randomised controlled trial
During the last decade, the use of ministernotomy in cardiac surgery has increased. Quality of life and patient satisfaction after ministernotomy have never been compared to conventional full sternotomy in randomised trials. The aim of the study is to determine if this minimally invasive approach improves quality of life, satisfaction and clinical morbimortality outcomes. The QUALITY-AVR trial is a single-blind, single-centre, independent, and pragmatic randomised clinical trial comparing ministernotomy (“J” shaped upper hemisternotomy toward right 4th intercostal space) to full sternotomy in patients with isolated severe aortic stenosis scheduled for elective aortic valve replacement. One hundred patients will be randomised in a 1:1 computational fashion. Sample size was determined for the primary end point with alpha error of 0.05 and with power of 90% in detecting differences between intervention groups of ≥ 0.10 points in change from baseline quality of life Questionnaire EuroQOL-index (EQ-5D-5 L®), measured at 1, 6 or 12 months. Secondary endpoints are: the differences in change from other baseline EQ-5D-5 L® utilities (visual analogue scale, Health Index and Severity Index), cardiac surgery specific satisfaction questionnaire (SATISCORE®), a combined safety endpoint of four major adverse complications at 1 month (all-cause mortality, acute myocardial infarction, neurologic events and acute renal failure), bleeding through drains within the first 24 h, intubation time, postoperative hospital and intensive care unit length of stay, transfusion needs during the first 72 h and 1-year survival rates. Clinical follow up is scheduled at baseline, 1, 6, and 12 months after randomization. All clinical outcomes are recorded following the Valve Academic Research Consortium 2 criteria. The QUALITY-AVR trial aims to test the hypothesis that ministernotomy improves quality of life, satisfaction and clinical outcomes in patients referred for isolated aortic valve replacement. Statistically significant differences favouring ministernotomy could modify the surgical “gold standard” for aortic stenosis surgery, and subsequently the need to change the control group in transcatheter aortic valve implantation trials. Recruitment started on 18 March 2016. In November 2017, 75 patients were enrolled. ClinicalTrials.gov, NCT02726087. Registered on 13 March 2016.
- Open Access
- 1 January 2018
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 25 (1) , 48-50
Rara complicación con un catéter de Swan-Ganz
- 1 January 2018
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 25 (1) , 48-50
Open AccessRara complicación con un catéter de Swan-Ganz
- 1 December 2017
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 35 (10) , 645-650
Endocarditis infecciosa sobre válvula aórtica bicúspide: características clínicas, complicaciones y pronóstico
- 1 December 2017
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 35 (10) , 645-650
Endocarditis infecciosa sobre válvula aórtica bicúspide: características clínicas, complicaciones y pronóstico
- 1 October 2017
- Published by Elsevier in Cardiocore
- Vol. 52 (4) , 138-141
La reparación valvular aórtica: luces y sombras
- 1 October 2017
- Published by Elsevier in Cardiocore
- Vol. 52 (4) , 138-141
La reparación valvular aórtica: luces y sombras
- Open Access
- 28 June 2017
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 25 (4) , 571-574
Increased blood levels of transforming growth factor β in patients with aortic dilatation
Recent studies have shown that patients with syndromic thoracic aortic aneurysm, particularly patients with bicuspid aortic valve, have increased blood levels of transforming growth factor β1 (TGF-β1), indicating this molecule as a prognostic biomarker. However, it is not known whether TGF-β1 is also elevated in the blood of patients with tricuspid aortic valve and aortic dilatation. We analysed the plasma levels of TGF-β1 in 52 patients with tricuspid or bicuspid aortic valve and with normal or dilated ascending aorta who underwent cardiac surgery in our hospital. TGF-β1 blood level was significantly increased two-fold in patients with tricuspid aortic valve and dilated aorta compared to patients with tricuspid aortic valve and normal aorta. Our results suggest that TGF-β1 blood levels may serve as a prognostic biomarker for patients with syndromic and non-syndromic thoracic aortic aneurysm. Further studies with larger cohorts of patients should be performed to confirm these results.
- 28 June 2017
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 25 (4) , 571-574
Open AccessIncreased blood levels of transforming growth factor β in patients with aortic dilatation
Recent studies have shown that patients with syndromic thoracic aortic aneurysm, particularly patients with bicuspid aortic valve, have increased blood levels of transforming growth factor β1 (TGF-β1), indicating this molecule as a prognostic biomarker. However, it is not known whether TGF-β1 is also elevated in the blood of patients with tricuspid aortic valve and aortic dilatation. We analysed the plasma levels of TGF-β1 in 52 patients with tricuspid or bicuspid aortic valve and with normal or dilated ascending aorta who underwent cardiac surgery in our hospital. TGF-β1 blood level was significantly increased two-fold in patients with tricuspid aortic valve and dilated aorta compared to patients with tricuspid aortic valve and normal aorta. Our results suggest that TGF-β1 blood levels may serve as a prognostic biomarker for patients with syndromic and non-syndromic thoracic aortic aneurysm. Further studies with larger cohorts of patients should be performed to confirm these results.
- Open Access
- 1 January 2017
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 14 (3) , 268-274
Expression of Sterol Regulatory Element-Binding Proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study
Objectives: Sterol regulatory element-binding proteins (SREBP) genes are crucial in lipid biosynthesis and cardiovascular homeostasis. Their expression in epicardial adipose tissue (EAT) and their influence in the development of coronary artery disease (CAD) and type-2 diabetes mellitus remain to be determined. The aim of our study was to evaluate the expression of SREBP genes in EAT in patients with CAD according to diabetes status and its association with clinical and biochemical data.
- 1 January 2017
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 14 (3) , 268-274
Open AccessExpression of Sterol Regulatory Element-Binding Proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: preliminary study
Objectives: Sterol regulatory element-binding proteins (SREBP) genes are crucial in lipid biosynthesis and cardiovascular homeostasis. Their expression in epicardial adipose tissue (EAT) and their influence in the development of coronary artery disease (CAD) and type-2 diabetes mellitus remain to be determined. The aim of our study was to evaluate the expression of SREBP genes in EAT in patients with CAD according to diabetes status and its association with clinical and biochemical data.
- Open Access
- 1 November 2016
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 23 (6) , 306-311
Cirugía valvular aórtica mínimamente invasiva
- 1 November 2016
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 23 (6) , 306-311
Open AccessCirugía valvular aórtica mínimamente invasiva
- Open Access
- 1 November 2016
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 23 (6) , 312-314
Prótesis aórticas sin sutura: revisión de las alternativas actuales
- 1 November 2016
- Published by Elsevier in Cirugía Cardiovascular
- Vol. 23 (6) , 312-314
Open AccessPrótesis aórticas sin sutura: revisión de las alternativas actuales